MarketPulse
G

$GRAL

4 articles found
1 positive
3 negative
0 neutral
The Motley FoolThe Motley Fool··Lee Samaha

Grail Stock Surges on Analyst Optimism Despite Cancer Test Setback

Grail stock jumped 11.4% as Wall Street analysts see upside in its cancer detection test despite February trial disappointment.
GRALFDA approvalcancer detection
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Law Firm Initiates Securities Investigation Into GRAIL Following Failed Cancer Trial

Law firm investigates GRAIL for potential securities violations after cancer trial failure triggered stock decline. Examining whether company adequately disclosed trial risks.
GRALinvestor lossesstock price decline
BenzingaBenzinga··Piero Cingari

Supreme Court Strikes Down Presidential Tariff Authority in 6-3 Decision

Supreme Court ruled 6-3 that President Trump lacked authority to impose tariffs without congressional approval, sparking market rally as trade barriers are invalidated.
MHAAOIGRALRNGCPRT+4Trump tariffsSupreme Court
BenzingaBenzinga··Rishabh Mishra

Equity Futures Pull Back on Softer-Than-Expected Fourth Quarter GDP Data

Stock futures fell Friday on weaker-than-expected Q4 GDP data. Mixed earnings reports and inflation figures kept investors focused on Fed policy ahead of March meeting.
SPYQQQGRALCPRTFIX+2earningsFederal Reserve